Old Web
English
Sign In
Acemap
>
authorDetail
>
Thomas Beveridge
Thomas Beveridge
Ipsen
Internal medicine
Medicine
Gastroenterology
Octreotide
Lanreotide
3
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Medical record review of transition to lanreotide following octreotide for neuroendocrine tumors
2019
Journal of gastrointestinal oncology
Muhammad Wasif Saif
Rohan Parikh
David Ray
James A. Kaye
Samantha Kurosky
Katharine Thomas
Robert A. Ramirez
Thorvardur R. Halfdanarson
Thomas Beveridge
Beloo Mirakhur
Saurabh P. Nagar
Heloisa P. Soares
Show All
Source
Cite
Save
Citations (2)
Tumor growth and regression rate constants from the CLARINET study as surrogate endpoints for progression free survival: A novel assessment approach in cancer therapy.
2018
Journal of Clinical Oncology
Clarisse Dromain
Arturo Loaiza-Bonilla
Thomas Beveridge
Beloo Mirakhur
Julia Wilkerson
Antonio Tito Fojo
Show All
Source
Cite
Save
Citations (0)
The sequencing of lanreotide (LAN) after octreotide LAR (OCT) for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
2018
Journal of Clinical Oncology
Wasif M. Saif
Rohan Parikh
David Ray
James A. Kaye
Samantha Kurosky
Katharine Thomas
Thomas Beveridge
Beloo Mirakhur
Catherine A Lubeck
Saurabh P. Nagar
Heloisa P. Soares
Show All
Source
Cite
Save
Citations (0)
1